735169009: Pazopanib hydrochloride (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Protein-tyrosine kinase inhibitor\Pazopanib hydrochloride (substance)
\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)\Pazopanib hydrochloride (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Pazopanib hydrochloride (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Sulfur and/or sulfur compound\Sulfur compound\Sulfone (substance)\Sulfonamide (substance)\Pazopanib hydrochloride (substance)

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\...

\Pyrimidine and/or pyrimidine derivative\Aminopyrimidine (substance)\Pazopanib hydrochloride (substance)

\Amide and/or amide derivative (substance)\Amide\Sulfonamide (substance)\Pazopanib hydrochloride (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Indazole (substance)\Pazopanib hydrochloride (substance)
\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyrimidine and/or pyrimidine derivative\Aminopyrimidine (substance)\Pazopanib hydrochloride (substance)
\Organic compound\Organic nitrogen compound\Pyrimidine and/or pyrimidine derivative\Aminopyrimidine (substance)\Pazopanib hydrochloride (substance)
\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Sulfonamide (substance)\Pazopanib hydrochloride (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Pazopanib hydrochloride (substance)	Is a	Pazopanib (substance)	false	Inferred relationship	Some
Pazopanib hydrochloride (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Protein-tyrosine kinase inhibitor (disposition)	true	Inferred relationship	Some
Pazopanib hydrochloride (substance)	Is a	Indazole (substance)	true	Inferred relationship	Some
Pazopanib hydrochloride (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Pazopanib (substance)	true	Inferred relationship	Some
Pazopanib hydrochloride (substance)	Is a	Aminopyrimidine (substance)	true	Inferred relationship	Some
Pazopanib hydrochloride (substance)	Is a	Protein-tyrosine kinase inhibitor	true	Inferred relationship	Some
Pazopanib hydrochloride (substance)	Is a	Sulfonamide (substance)	true	Inferred relationship	Some
Pazopanib hydrochloride (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Vascular endothelial growth factor receptor antagonist (disposition)	true	Inferred relationship	Some
Pazopanib hydrochloride (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Pazopanib hydrochloride (substance)	Is a	Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)	true	Inferred relationship	Some
Pazopanib hydrochloride (substance)	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely pazopanib (as pazopanib hydrochloride) 200 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Pazopanib hydrochloride (substance)	Inferred relationship	Some	1
Product containing precisely pazopanib (as pazopanib hydrochloride) 400 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Pazopanib hydrochloride (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3513343014	Pazopanib hydrochloride (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3513344015	Pazopanib hydrochloride	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4927201000005111	pazopanibhydrochlorid	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)
4927211000005114	pazopanib hydrochloride	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)